Spread of a low-fitness drug-resistant Mycobacterium tuberculosis strain in a setting of high human immunodeficiency virus prevalence

J Clin Microbiol. 2008 Apr;46(4):1514-6. doi: 10.1128/JCM.01938-07. Epub 2008 Feb 13.

Abstract

The fitness cost associated with the evolution of resistance to rifampin in Mycobacterium tuberculosis may be different in clinical isolates compared to in vitro-generated mutants. An atypical Beijing strain (attenuated phenotype) demonstrated the ability to spread despite acquiring resistance to rifampin. Transmission was linked to human immunodeficiency virus coinfection (P = 0.029), raising concern for the spread of drug resistance in vulnerable populations.

Publication types

  • Research Support, N.I.H., Extramural
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Antibiotics, Antitubercular / pharmacology*
  • Codon / genetics
  • Drug Resistance, Bacterial
  • Genotype
  • HIV Infections / complications*
  • HIV Infections / epidemiology
  • HIV Infections / virology
  • HIV-1
  • Humans
  • Microbial Sensitivity Tests
  • Mutation
  • Mycobacterium tuberculosis / classification
  • Mycobacterium tuberculosis / drug effects*
  • Mycobacterium tuberculosis / genetics
  • Polymorphism, Single Nucleotide
  • Prevalence
  • Rifampin / pharmacology*
  • South Africa / epidemiology
  • Tuberculosis, Multidrug-Resistant / complications*
  • Tuberculosis, Multidrug-Resistant / epidemiology
  • Tuberculosis, Multidrug-Resistant / microbiology
  • Tuberculosis, Multidrug-Resistant / transmission*

Substances

  • Antibiotics, Antitubercular
  • Codon
  • Rifampin